News Focus
News Focus
icon url

SanDiegoLiving

07/02/25 4:42 PM

#437146 RE: SanDiegoLiving #437145

Note: This does not include any angle of fraud from North's filings.
icon url

rosemountbomber

07/02/25 4:57 PM

#437147 RE: SanDiegoLiving #437145

Thanks for posting. Yeoman work.  Appreciate the time and effort.  It answers my question as to at least what the SG is mostly likely to recommend. 
icon url

ProLiberty

07/02/25 5:18 PM

#437148 RE: SanDiegoLiving #437145

Thank you. When should we hear? How does the pending first patent response for thyroid-delivery technology factor in?
icon url

CaptBeer

07/03/25 4:42 AM

#437152 RE: SanDiegoLiving #437145

Wow this was outstanding analysis! Thanks for this thought provoking work. Here are some of my thoughts:
Your promptings seemed to be geared toward what would the SG's recommendations be. CHAT's conclusion was that the SG had an 80% chance of siding with Hikma. I didn't see a follow-up prompt as to the probability that SCOTUS would grant the Cert. we know from GSK v TEVA that SCOTUS denied Cert despite the SG's recommendation. We also know that around 7,000 Cert. requests are made each year with about 1% being granted. 
Furthermore, SCOTUS prefers to review cases that have been fully adjudicated. Discovery is well underway and I believe that SCOTUS will let this play out.